Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

SEC Levels $29.4 Million Fine Against Lilly for FCPA Violations
Motley Fool
Friday, December 21, 2012 - 10:14am
tags:
SEC, FCPA, Eli Lilly
Amgen whistleblower went undercover for the feds
Fierce Pharma
Thursday, December 20, 2012 - 11:23am
tags:
whistleblowers, Amgen
There is Life After Patent Expirations: Why Pfizer and Lilly Stocks Rebounded
Forbes
Thursday, December 20, 2012 - 11:19am
tags:
patents, Pfizer, Lipitor, Eli Lilly, Zyprexa
Roche Favors Deals Up to $7 Billion Over Buybacks, CFO Says
Bloomberg
Thursday, December 20, 2012 - 11:17am
tags:
Roche, M&A
Biogen Idec Forms First-of-Its-Kind Research Consortium to Identify ALS Drug Targets
Yahoo
Thursday, December 20, 2012 - 11:15am
tags:
Biogen Idec, ALS, amyotrophic lateral sclerosis
Dendreon Sells New Jersey Immunotherapy Manufacturing Facility
Yahoo
Thursday, December 20, 2012 - 11:14am
tags:
Dendreon, manufacturing, New Jersey
Illumina Shares Gain on Report of Higher Roche Bid
Bloomberg
Thursday, December 20, 2012 - 11:13am
tags:
Roche, Illumina, M&A
Merck Niacin Drug Failure Could Have Broad Repercussions
Forbes
Thursday, December 20, 2012 - 11:12am
tags:
Merck, Tredaptive
Sanofi Pays $109M To Settle Kickback Charges
Pharmalot
Thursday, December 20, 2012 - 10:52am
tags:
Sanofi, kickbacks, Hyalgan
Stada Surges as Takeover Speculation Resurfaces
Bloomberg
Thursday, December 20, 2012 - 10:51am
tags:
Stada, M&A
FDA Denies Merck Request to Block Generic Form of Nasonex
FOX Business
Thursday, December 20, 2012 - 10:49am
tags:
FDA, Merck, Nasonex, generics, Apotex
Amicus Fabry Drug Fails Pivotal Trial
TheStreet.com
Thursday, December 20, 2012 - 10:45am
tags:
Amicus, Fabry's disease, Amigal, GSK
Rigel Recovers On 2013 Hope For Its Rheumatoid Arthritis Drug
Seeking Alpha
Thursday, December 20, 2012 - 10:40am
tags:
Rigel, rheumatoid arthritis, fostamatinib, AstraZeneca
Endo Health Loses Suit to Stop Sales of Generic Painkiller
Bloomberg
Thursday, December 20, 2012 - 10:40am
tags:
Endo Health Solutions, painkillers, generics, Opana ER
Merck cholesterol drug fails; risks seen
Reuters
Thursday, December 20, 2012 - 10:39am
tags:
Merck, HDL cholesterol, Tredaptive
U.S. court approves Amgen's $762 mln payment in drug case
Reuters
Wednesday, December 19, 2012 - 3:27pm
tags:
Amgen, misbranding, Aranesp
Celgene inks $500M-plus deal with ADC developer Sutro
Fierce Pharma
Wednesday, December 19, 2012 - 1:35pm
tags:
Celgene, Sutro
Vivus, Dendreon Set To Rally From The January Effect
Seeking Alpha
Wednesday, December 19, 2012 - 1:35pm
tags:
Dendreon, Vivus, Provenge, Qsymia
When Compared To Isis, Alnylam's Valuation Does Not Make Sense
Seeking Alpha
Wednesday, December 19, 2012 - 1:32pm
tags:
Isis Pharmaceuticals, Alnylam
Vertex strengthens warning with hepatitis C drug
Reuters
Wednesday, December 19, 2012 - 1:31pm
tags:
Vertex, hepatitis C, Incivek

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.